How similar do 'biosimilars' need to be?
- 1 November 2004
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 22 (11) , 1357-1359
- https://doi.org/10.1038/nbt1104-1357
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Pure Red-Cell Aplasia and Epoetin TherapyNew England Journal of Medicine, 2004
- When biotech proteins go off-patentTrends in Biotechnology, 2004
- Lessons from Eprex for biogeneric firmsNature Biotechnology, 2003
- Bioequivalence and the immunogenicity of biopharmaceuticalsNature Reviews Drug Discovery, 2002